z-logo
Premium
Chronic lung disease in very low birthweight infants: A prospective population‐based study
Author(s) -
DARLOW B. A.,
HORWOOD L. J.
Publication year - 1992
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/j.1440-1754.1992.tb02672.x
Subject(s) - medicine , gestation , respiratory distress , prospective cohort study , lung disease , population , pediatrics , logistic regression , birth weight , respiratory disease , gestational age , oxygen therapy , lung , obstetrics , pregnancy , surgery , genetics , environmental health , biology
A prospective population‐based study of chronic lung disease among all very low birthweight infants (birthweight 500–1499 g) born in New Zealand in 1986 is reported. Of 413 of these infants admitted to neonatal units, 355 (86%) survived to 28 days. An additional 50 infants were recorded as liveborn but died in the labour ward or other place of birth. Both observed survival and survival adjusted for birthweight, gestation and gender were significantly ( P <0.05) better in larger centres. Oxygen requirement was assessed at 28 days of age, 36 weeks equivalent gestation and 84 days of age, when 38.6,23.1 and 13.8% of infants, respectively, were being treated with oxygen. To examine the joint effects of predictor variables on oxygen requirement at each age, the data were analysed using multiple logistic regression methods. At 28 days, lower birthweight, shorter gestation, respiratory distress syndrome (all P <0.0001), and gender and hospital principally caring for the infant (both P <0.05) were significantly associated with treatment with oxygen. In comparison with other studies, New Zealand appears to have a relatively high rate of chronic lung disease. We speculate that a contributing factor may be the small size of some regional neonatal units.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here